Similarly, CD34 IHC staining did not show significant difference of angiogenesis between the “metronomic Celecoxib” group and the placebo group in both syngeneic HCC and spontaneous HCC in vivo models (Figures 5C–H). The gene discussed is CD34; the disease is hepatocellular carcinoma.